Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 1/20 | 0.41 |
| ▸ | MRGPRX4 | Q96LA9 | 12/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | THRA | P10827 | 2/20 | 0.36 |
| ▸ | THRB | P10828 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13817512 | 0.95 | FFAR1 (0.39) | FFAR1MRGPRX4ALDH1A1MEN1KMT2A | |
| SCHEMBL4491357 | 0.91 | FFAR1 (0.40) | FFAR1MRGPRX4ALDH1A1MEN1KMT2A | |
| SCHEMBL13817513 | 0.86 | FFAR1 (0.38) | FFAR1MRGPRX4ALDH1A1MEN1KMT2A | |
| SCHEMBL4486868 | 0.85 | FFAR1 (0.42) | FFAR1MRGPRX4ALDH1A1MEN1KMT2A | |
| SCHEMBL4489548 | 0.84 | MAPK1 (0.45) | FFAR1MRGPRX4 | |
| SCHEMBL3103497 | 0.83 | RORC (0.45) | FFAR1MRGPRX4ALDH1A1MEN1KMT2A | |
| SCHEMBL13817517 | 0.81 | FFAR1 (0.41) | FFAR1MRGPRX4ALDH1A1MEN1KMT2A | |
| SCHEMBL4499433 | 0.80 | FAAH (0.40) | FFAR1ALDH1A1MEN1KMT2A | |
| SCHEMBL13817535 | 0.80 | NPSR1 (0.44) | ALDH1A1MEN1KMT2A | |
| SCHEMBL3109428 | 0.79 | RORC (0.41) | FFAR1MRGPRX4ALDH1A1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7541472-B2 | 3-Aryl-3-hydroxy-2-methylenepropionic acid esters as fungicides | CROPSOLUTION, INC. (US) | 2009-06-02 | — | — | US | disclosed |
| US-7541472-B2 | 3-Aryl-3-hydroxy-2-methylenepropionic acid esters as fungicides | CROPSOLUTION, INC. (US) | 2009-06-02 | — | — | US | disclosed |
| US-7541472-B2 | 3-Aryl-3-hydroxy-2-methylenepropionic acid esters as fungicides | CROPSOLUTION, INC. (US) | 2009-06-02 | — | — | US | disclosed |
| US-20060094739-A1 | 3-Aryl-3-hydroxy-2-methylenepropionic acid esters as fungicides | ATP CAPITAL LP | 2006-05-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060094739-A1 | 3-Aryl-3-hydroxy-2-methylenepropionic acid esters as fungicides | CYP51A1, DDT, CYP21A2 | FFAR1 304/4885MRGPRX4 2010/4885ALDH1A1 62/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.